1. From Georg-Speyer-Haus, Frankfurt am Main, Germany; the Department of Hematology and Oncology, University of Regensburg, Regensburg, Germany; the Neurological Institute (Edinger Institute), University of Frankfurt/Main, Germany; and Bayer AG, Pharma Research Center, Wuppertal, Germany.